{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T00:41:09Z","timestamp":1772066469192,"version":"3.50.1"},"reference-count":23,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","license":[{"start":{"date-parts":[[2013,1,1]],"date-time":"2013-01-01T00:00:00Z","timestamp":1356998400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2013,1]]},"DOI":"10.1016\/j.juro.2012.08.191","type":"journal-article","created":{"date-parts":[[2012,11,19]],"date-time":"2012-11-19T10:00:55Z","timestamp":1353319255000},"page":"380-384","source":"Crossref","is-referenced-by-count":29,"title":["A Comparative Study of the Efficacy of Intralesional Verapamil Versus Normal Saline Injection in a Novel Peyronie Disease Animal Model: Assessment of Immunohistopathological Changes and Erectile Function Outcome"],"prefix":"10.1097","volume":"189","author":[{"given":"Eric","family":"Chung","sequence":"first","affiliation":[{"name":"Division of Urology, St. Joseph Health Care, London, Ontario, Canada"},{"name":"Department of Urology, Princess Alexandra Hospital, Brisbane, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"Garcia","sequence":"additional","affiliation":[{"name":"Division of Urology, St. Joseph Health Care, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"De Young","sequence":"additional","affiliation":[{"name":"Department of Urology, Lawson Health Research Institute, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Solomon","sequence":"additional","affiliation":[{"name":"Division of Urology, St. Joseph Health Care, London, Ontario, Canada"},{"name":"Department of Urology, Princess Alexandra Hospital, Brisbane, Queensland, Australia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald B.","family":"Brock","sequence":"additional","affiliation":[{"name":"Department of Urology, Lawson Health Research Institute, London, Ontario, Canada"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2012.08.191_bib1","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1111\/j.1743-6109.2010.01850.x","article-title":"The management of Peyronie's disease: evidence-based 2010 guidelines","volume":"7","author":"Ralph","year":"2010","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2012.08.191_bib2","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1016\/S0022-5347(17)35291-6","article-title":"Intralesional verapamil injection for the treatment of Peyronie's disease","volume":"151","author":"Levine","year":"1994","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.08.191_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0022-5347(05)64691-5","article-title":"Experience with intraplaque injection of verapamil for Peyronie's disease","volume":"168","author":"Levine","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.08.191_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0090-4295(97)00700-0","article-title":"Use of intralesional verapamil to dissolve Peyronie's disease plaque: a long-term single-blind study","volume":"51","author":"Rehman","year":"1998","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.08.191_bib5","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1016\/j.urology.2007.02.042","article-title":"Intralesional verapamil prevents the progression of Peyronie's disease","volume":"69","author":"Bennet","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.08.191_bib6","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.urology.2007.01.080","article-title":"Open preliminary randomized prospective clinical trial of efficacy and safety of three different verapamil dilutions for intraplaque therapy of Peyronie's disease","volume":"69","author":"Cavallini","year":"2007","journal-title":"Urology"},{"key":"10.1016\/j.juro.2012.08.191_bib7","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0302-2838(02)00225-7","article-title":"A new biopsy technique to investigate Peyronie's disease associated histologic alterations: results with two different forms of therapy","volume":"42","author":"Mirone","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2012.08.191_bib8","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0022-5347(06)00517-9","article-title":"Single-blind, multicenter, placebo controlled, parallel study to assess the safety and efficacy of intralesional interferon alpha-2B for minimally invasive treatment for Peyronie's disease","volume":"176","author":"Hellstrom","year":"2006","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2012.08.191_bib9","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s11255-009-9522-4","article-title":"Effect of intralesional verapamil for treatment of Peyronie's disease: a randomised single-blind, placebo-controlled study","volume":"41","author":"Shirazi","year":"2009","journal-title":"Int Urol Nephol"},{"key":"10.1016\/j.juro.2012.08.191_bib10","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1038\/ijir.2011.36","article-title":"Rat as an animal model for Peyronie's disease research: a review of current methods and the peer reviewed literature","volume":"23","author":"Chung","year":"2011","journal-title":"Int J Impot Res"},{"key":"10.1016\/j.juro.2012.08.191_bib11","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1038\/sj.ijir.3900558","article-title":"Inhibition of Peyronie's plaque fibroblast proliferation by biologic agents","volume":"12","author":"Anderson","year":"2000","journal-title":"Int J Impot Res"},{"issue":"suppl.","key":"10.1016\/j.juro.2012.08.191_bib12","first-page":"S51","article-title":"A novel rat model for Peyronie's disease that demonstrates durability and functional detriments","volume":"6","author":"Garcia","year":"2012","journal-title":"Can Urol Assoc J"},{"key":"10.1016\/j.juro.2012.08.191_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1046\/j.1464-410x.1998.00529.x","article-title":"Histological and ultrastructural alterations in an animal model of Peyronie's disease","volume":"81","author":"El-Sakka","year":"1998","journal-title":"Br J Urol"},{"key":"10.1016\/j.juro.2012.08.191_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/j.1365-2605.2007.00780.x","article-title":"Repeated intratunical injection of adenovirus expressing transforming growth factor-beta 1 in rat induces penile curvature with tunical fibrotic plaque: a useful model for the study of Peyronie's disease","volume":"31","author":"Piao","year":"2007","journal-title":"Int J Androl"},{"key":"10.1016\/j.juro.2012.08.191_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/0022-4804(90)90197-A","article-title":"Calcium antagonists retard extracellular matrix production in connective tissue equivalent","volume":"49","author":"Lee","year":"1990","journal-title":"J Surg Res"},{"key":"10.1016\/j.juro.2012.08.191_bib16","doi-asserted-by":"crossref","first-page":"5478","DOI":"10.1073\/pnas.93.11.5478","article-title":"Ca2+ channel blockers modulate metabolism of collagens with the extracellular matrix","volume":"93","author":"Roth","year":"1996","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/j.juro.2012.08.191_bib17","first-page":"154","article-title":"Matrix metalloproteinases","volume":"271","author":"Nagase","year":"1996","journal-title":"J Biol Chem"},{"key":"10.1016\/j.juro.2012.08.191_bib18","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/S1089-8603(02)00124-6","article-title":"Effect of nitric oxide on the differentiation of fibroblasts into myofibroblasts in the Peyronie's fibrotic plaque and in its rat model","volume":"7","author":"Vernet","year":"2002","journal-title":"Nitric Oxide"},{"key":"10.1016\/j.juro.2012.08.191_bib19","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/0014-4800(90)90003-V","article-title":"Effects of collagen matrix on proliferation and differentiation of vascular smooth muscle cells in vitro","volume":"52","author":"Sakata","year":"1990","journal-title":"Exp Mol Pathol"},{"key":"10.1016\/j.juro.2012.08.191_bib20","doi-asserted-by":"crossref","first-page":"21505","DOI":"10.1016\/S0021-9258(17)31833-1","article-title":"Calcium influx modulates expression of matrix metalloproteinase-2 (72-kDa type IV collagenase, gelatinase A)","volume":"269","author":"Kohn","year":"1994","journal-title":"J Bio Chem"},{"key":"10.1016\/j.juro.2012.08.191_bib21","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1111\/j.1743-6109.2009.01216.x","article-title":"IN-1130, a novel transforming growth factor-\u03b2 Type 1 receptor kinase (activin receptor-like kinase 5) inhibitor, promotes regression of fibrotic plaque and corrects penile curvature in a rat model of Peyronie's disease","volume":"6","author":"Ryu","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/j.juro.2012.08.191_bib22","doi-asserted-by":"crossref","first-page":"PE6","DOI":"10.1126\/stke.2002.119.pe6","article-title":"Mechanotransduction: all signals point to cytoskeleton, matrix and integrins","volume":"2002","author":"Alenghat","year":"2002","journal-title":"Sci STKE"},{"key":"10.1016\/j.juro.2012.08.191_bib23","doi-asserted-by":"crossref","first-page":"3743","DOI":"10.1111\/j.1743-6109.2010.01924.x","article-title":"Nicardipine vs. saline injection as treatment for Peyronie's disease: a prospective, randomized, single-blind trial","volume":"7","author":"Soh","year":"2010","journal-title":"J Sex Med"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712048100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534712048100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2012.08.191","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T03:00:09Z","timestamp":1651201209000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2012.08.191"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1]]},"references-count":23,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,1]]}},"alternative-id":["10.1016\/j.juro.2012.08.191"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2012.08.191","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1]]}}}